How obstructive sleep apnea affects glucose metabolism
Mechanisms of Prediabetic States in Obstructive Sleep Apnea
This study is looking at how obstructive sleep apnea might affect blood sugar levels in people with prediabetes, and it will explore whether using a CPAP machine can help improve their insulin sensitivity and overall glucose metabolism.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10674545 on NIH RePORTER |
What this research studies
This research investigates the relationship between obstructive sleep apnea (OSA) and impaired glucose metabolism, particularly in individuals with prediabetes. The study aims to understand how OSA increases sympathetic activity, leading to higher levels of free fatty acids in the bloodstream, which may contribute to insulin resistance. By examining the effects of OSA on adipose tissue and skeletal muscle metabolism, the research seeks to uncover the underlying mechanisms that link OSA to glucose intolerance. Participants may undergo assessments involving continuous positive airway pressure (CPAP) treatment to evaluate its impact on insulin sensitivity and glucose metabolism.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with obstructive sleep apnea who also have prediabetes or are at risk for developing diabetes.
Not a fit: Patients without obstructive sleep apnea or those who do not have issues with glucose metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for prediabetes in patients with obstructive sleep apnea, enhancing their metabolic health.
How similar studies have performed: Previous research has shown that treating obstructive sleep apnea can improve insulin sensitivity, indicating potential success for this approach.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Tasali, Esra — University of Chicago
- Study coordinator: Tasali, Esra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.